These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3580514)

  • 1. Lack of effect of multiple doses of cimetidine on estimated hepatic blood flow.
    Grasela DM; Rocci ML; Rotmensch HH; Vlasses PH
    Biopharm Drug Dispos; 1987; 8(1):63-72. PubMed ID: 3580514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of single doses of cimetidine on estimated hepatic blood flow.
    Rocci ML; Grasela DM; Fruncillo RJ; Vlasses PH
    Drug Intell Clin Pharm; 1985 Nov; 19(11):831-4. PubMed ID: 4064917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of liver blood flow and propranolol metabolism by cimetidine.
    Feely J; Wilkinson GR; Wood AJ
    N Engl J Med; 1981 Mar; 304(12):692-5. PubMed ID: 7464861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indocyanine green clearance following single and chronic cimetidine doses.
    MacKichan JJ; Schaal SF; Stine RA; Boudoulas H
    Res Commun Chem Pathol Pharmacol; 1984 May; 44(2):323-6. PubMed ID: 6739959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the influence of famotidine and cimetidine on phenytoin elimination and hepatic blood flow.
    Sambol NC; Upton RA; Chremos AN; Lin ET; Williams RL
    Br J Clin Pharmacol; 1989 Jan; 27(1):83-7. PubMed ID: 2565119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic oral cimetidine on apparent liver blood flow and hepatic microsomal enzyme activity in man.
    Daneshmend TK; Ene MD; Parker G; Roberts CJ
    Gut; 1984 Feb; 25(2):125-8. PubMed ID: 6693040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cimetidine does not reduce liver blood flow in cirrhosis.
    Henderson JM; Ibrahim SZ; Millikan WJ; Santi M; Warren WD
    Hepatology; 1983; 3(6):919-22. PubMed ID: 6629321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cimetidine and hepatic blood flow in polytrauma patients.
    Ivatury RR; Khan MB; Nallathambi M; Davis K; Stahl WM
    Crit Care Med; 1985 May; 13(5):436-7. PubMed ID: 3987323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of hepatic blood flow in chronic liver diseases using the constant infusion technic].
    Vorobioff J; Carnovale C; Topol R; Picabea E; Villavicencio R; Tanno H; Audano M; Audano G
    Acta Gastroenterol Latinoam; 1984; 14(3):229-34. PubMed ID: 6537116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of effect of histamine H2-receptor antagonists on indocyanine green disposition measured by two methods.
    Donn KH; Powell JR; Rogers JF; Plachetka JR
    J Clin Pharmacol; 1984; 24(8-9):360-70. PubMed ID: 6148361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetic basis for H2-antagonist drug interactions: concepts and implications.
    Powell JR; Donn KH
    J Clin Gastroenterol; 1983; 5 Suppl 1():95-113. PubMed ID: 6140286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cimetidine on verapamil disposition.
    Loi CM; Rollins DE; Dukes GE; Peat MA
    Clin Pharmacol Ther; 1985 Jun; 37(6):654-7. PubMed ID: 4006365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cimetidine on the hepatic extraction of indocyanine green, the portal pressure and the systemic circulation in patients with cirrhosis of the liver.
    Herz R; Rössle M; Bonzel T; Keller E; Gerok W
    Klin Wochenschr; 1984 Aug; 62(16):759-64. PubMed ID: 6482311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological and pharmacological variability in estimated hepatic blood flow in man.
    Daneshmend TK; Jackson L; Roberts CJ
    Br J Clin Pharmacol; 1981 May; 11(5):491-6. PubMed ID: 6115663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green.
    Soons PA; De Boer A; Cohen AF; Breimer DD
    Br J Clin Pharmacol; 1991 Dec; 32(6):697-704. PubMed ID: 1768562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cimetidine does not alter morphine disposition in man.
    Mojaverian P; Fedder IL; Vlasses PH; Rotmensch HH; Rocci ML; Swanson BN; Ferguson RK
    Br J Clin Pharmacol; 1982 Dec; 14(6):809-13. PubMed ID: 7150459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of the estimation of total hepatic blood flow by Doppler ultrasound in patients with cirrhotic portal hypertension.
    Berzigotti A; Reverter E; García-Criado A; Abraldes JG; Cerini F; García-Pagán JC; Bosch J
    J Hepatol; 2013 Oct; 59(4):717-22. PubMed ID: 23669282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indocyanine green plasma clearance as a measure of changes in hepatic blood flow.
    Kanstrup IL; Winkler K
    Clin Physiol; 1987 Feb; 7(1):51-4. PubMed ID: 3816112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antiorthostatic bed rest on hepatic blood flow in man.
    Putcha L; Cintron NM; Vanderploeg JM; Chen Y; Habis J; Adler J
    Aviat Space Environ Med; 1988 Apr; 59(4):306-8. PubMed ID: 3370038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enprostil, in contrast to cimetidine, does not inhibit propranolol metabolism.
    Reilly CS; Biollaz J; Koshakji RP; Wood AJ
    Clin Pharmacol Ther; 1986 Jul; 40(1):37-41. PubMed ID: 3087677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.